Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1- acetyltransferase

49Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Intracellular polyamine pools are homeostatically maintained by processes involving biosynthesis, catabolism, and transport. Although most polyamine-based anticancer strategies target biosynthesis, we recently showed that activation of polyamine catabolism at the level of spermidine/spermine N 1-acetyltransferase-1 (SSAT) suppresses tumor outgrowth in a mouse prostate cancer model. Herein, we examined the effects of differential SSAT expression on intestinal tumorigenesis in the ApcMin/+ (MIN) mouse. When MIN mice were crossed with SSAT-overproducing transgenic mice, they developed 3- and 6-fold more adenomas in the small intestine and colon, respectively, than normal MIN mice. Despite accumulation of the SSAT product, N1-acetylspermidine, spermidine and spermine pools were only slightly decreased due to a huge compensatory increase in polyamine biosynthetic enzyme activities that gave rise to enhanced metabolic flux. When MIN mice were crossed with SSAT knock-out mice, they developed 75% fewer adenomas in the small intestine, suggesting that under basal conditions, SSAT contributes significantly to the MIN phenotype. Despite the loss in catabolic capability, tumor spermidine and spermine pools failed to increase significantly due to a compensatory decrease in biosynthetic enzyme activity giving rise to a reduced metabolic flux. Loss of heterozygosity at the Apc locus was observed in tumors from both SSAT-transgenic and -deficient MIN mice, indicating that loss of heterozygosity remained the predominant oncogenic mechanism. Based on these data, we propose a model in which SSAT expression alters flux through the polyamine pathway giving rise to metabolic events that promote tumorigenesis. The finding that deletion of SSAT reduces tumorigenesis suggests that small-molecule inhibition of the enzyme may represent a nontoxic prevention and/or treatment strategy for gastrointestinal cancers. © 2005 American Association for Cancer Research.

References Powered by Scopus

Identification of c-MYC as a target of the APC pathway

4217Citations
N/AReaders
Get full text

Stromal fibroblasts in cancer initiation and progression

1988Citations
N/AReaders
Get full text

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

1410Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

649Citations
N/AReaders
Get full text

Polyamine catabolism and disease

323Citations
N/AReaders
Get full text

Spermidine/spermine-N<sup>1</sup>-acetyltransferase: A key metabolic regulator

294Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tucker, J. M., Murphy, J. T., Kisiel, N., Diegelman, P., Barbour, K. W., Davis, C., … Berger, F. G. (2005). Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1- acetyltransferase. Cancer Research, 65(12), 5390–5398. https://doi.org/10.1158/0008-5472.CAN-05-0229

Readers' Seniority

Tooltip

Professor / Associate Prof. 4

33%

PhD / Post grad / Masters / Doc 4

33%

Researcher 4

33%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 8

62%

Biochemistry, Genetics and Molecular Bi... 3

23%

Chemistry 2

15%

Save time finding and organizing research with Mendeley

Sign up for free